Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Overweight and obese individuals are encouraged to lose 5–10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: We conducted an observational analysis of participants in the Look AHEAD (Action For Health in Diabetes) study (n = 5,145, 40.5% male, 37% from ethnic/racial minorities) and examined the association between the magnitude of weight loss and changes in CVD risk factors at 1 year and the odds of meeting predefined criteria for clinically significant improvements in risk factors in individuals with type 2 diabetes. RESULTS: The magnitude of weight loss at 1 year was strongly (P < 0.0001) associated with improvements in glycemia, blood pressure, tryiglycerides, and HDL cholesterol but not with LDL cholesterol (P = 0.79). Compared with weight-stable participants, those who lost 5 to <10% ([means ± SD] 7.25 ± 2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81–4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20–1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27–1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37–2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71–2.83]). The odds of clinically significant improvements in most risk factors were even greater in those who lost 10–15% of their body weight. CONCLUSIONS: Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“behavioral weight loss (BWL) is the gold-standard non-surgical treatment for weight loss”
From Associations Between Self-Monitoring and Weight Change in Behavioral Weight Loss Interventions (2019) · cites this paper as Wing et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight loss across a spectrum of elevated BMIs produces not only improvements in glucose levels and the traditional cardiovascular intermediate risk factors 28 but also reductions in ectopic adipose tissue depots that may contribute to atherosclerosis and myocardial dysfunction. 29”
From Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These reductions are associated in a generally linear manner with improvements in cardiovascular disease (CVD) risk factors, quality of life, and prevention of type 2 diabetes [24–26].”
From The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities (2023) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For people living with obesity, losing 5% to 10% of body weight can lead to a substantial reduction in risk factors for diabetes, cardiovascular disease, and stroke [8].”
From Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It should be noted, however, that the clinical benefits of weight loss are progressive, and more intensive weight loss goals (i.e., 15%) may be appropriate to maximize benefit depending on need, feasibility, and safety (106,107).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023 (2023) · cites this paper as [107]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
(1998) · PubMed · Cited by 2,737
Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522
Beneficial health effects of modest weight loss.
Dj, G. (1992) · PubMed · Cited by 1,263
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162
Self-citationThe Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It
The Look AHEAD Research Group (2006) · Obesity · doi:10.1038/oby.2006.84 · Cited by 873
The Look AHEAD Research Group (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00064-3 · Cited by 767
Cited by
Items 101–200 of 1,007
Thompson, S. V., Hannon, B. A., An, R., & Holscher, H. D. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.163246 · Cited by 201
Anti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
Costanzo, P., Cleland, J. G. F., Pellicori, P., Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J., & Atkin, S. L. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1551 · Cited by 199
“Obese patients with type 2 diabetes might not have diabetes if they lost weight (34).”
BackgroundHaase, C. L., Lopes, S., Olsen, A. H., Satylganova, A., Schnecke, V., & McEwan, P. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00788-4 · Cited by 199
Five-Year Outcomes of Endoscopic Sleeve Gastroplasty for the Treatment of Obesity
Sharaiha, R. Z., Hajifathalian, K., Kumar, R., Saunders, K., Mehta, A., Ang, B., Skaf, D., Shah, S., Herr, A., Igel, L., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.09.055 · Cited by 191
Obesity increases the risk of end-stage renal disease among living kidney donors
Locke, J. E., Reed, R. D., Massie, A., MacLennan, P. A., Sawinski, D., Kumar, V., Mehta, S., Mannon, R. B., Gaston, R., Lewis, C. E., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.014 · Cited by 191
A systematic review and meta‐analysis of the effectiveness of meal replacements for weight loss
Astbury, N. M., Piernas, C., Hartmann‐Boyce, J., Lapworth, S., Aveyard, P., & Jebb, S. A. (2019) · Obesity Reviews · doi:10.1111/obr.12816 · Cited by 190
Guldbrand, H., Dizdar, B., Bunjaku, B., Lindström, T., Bachrach-Lindström, M., Fredrikson, M., Östgren, C. J., & Nystrom, F. H. (2012) · Diabetologia · doi:10.1007/s00125-012-2567-4 · Cited by 189
The Obesity Epidemic: The USA as a Cautionary Tale for the Rest of the World
Imes, C. C., & Burke, L. E. (2014) · Current Epidemiology Reports · doi:10.1007/s40471-014-0012-6 · Cited by 188
Complexity and Stigma of Pediatric Obesity
Haqq, A. M., Kebbe, M., Tan, Q., Manco, M., & Salas, X. R. (2021) · Childhood Obesity · doi:10.1089/chi.2021.0003 · Cited by 185
Obesity in South and Southeast Asia—A new consensus on care and management
Tham, K. W., Abdul Ghani, R., Cua, S. C., Deerochanawong, C., Fojas, M., Hocking, S., Lee, J., Nam, T. Q., Pathan, F., Saboo, B., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13520 · Cited by 187
Sun, J., & Buys, N. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1071872 · Cited by 186
Ghrelin regulation of glucose metabolism
Poher, A.-L., Tschöp, M. H., & Müller, T. D. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.015 · Cited by 186
Diabetes Mellitus and Cardiovascular Disease: Emerging Therapeutic Approaches
Schmidt, A. M. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.310961 · Cited by 183
Blüher, M. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16263 · Cited by 175
Anti-diabetic drugs and weight loss in patients with type 2 diabetes
Lazzaroni, E., Ben Nasr, M., Loretelli, C., Pastore, I., Plebani, L., Lunati, M. E., Vallone, L., Bolla, A. M., Rossi, A., Montefusco, L., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105782 · Cited by 182
“Weight-loss of 5-10%, not only improves glycemic control, but also influences cardiovascular risk factors, such as hypertension and dyslipidemia [6, 7].”
BackgroundEzpeleta, M., Gabel, K., Cienfuegos, S., Kalam, F., Lin, S., Pavlou, V., Song, Z., Haus, J. M., Koppe, S., Alexandria, S. J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.001 · Cited by 181
Sullivan, S., Swain, J. M., Woodman, G., Antonetti, M., De La Cruz‐Muñoz, N., Jonnalagadda, S. S., Ujiki, M., Ikramuddin, S., Ponce, J., Ryou, M., et al. (2017) · Obesity · doi:10.1002/oby.21702 · Cited by 179
“Numerous studies have demonstrated that moderate, sustained weight loss, as little as 5% in adults, can provide clinically significant benefits to subject health and has subsequently become the recommended benchmark to determine weight loss procedure efficacy (18-21).”
BackgroundNaslund, J. A., Whiteman, K. L., McHugo, G. J., Aschbrenner, K. A., Marsch, L. A., & Bartels, S. J. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.04.003 · Cited by 176
Azami, G., Soh, K. L., Sazlina, S. G., Salmiah, M. S., Aazami, S., Mozafari, M., & Taghinejad, H. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4930157 · Cited by 174
Management of Preexisting Diabetes in Pregnancy: A Review
Alexopoulos, A.-S., Blair, R., & Peters, A. L. (2019) · JAMA · doi:10.1001/jama.2019.4981 · Cited by 174
Self-citationBays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.04.001 · Cited by 166
Dietary strategies implicated in the prevention and treatment of metabolic syndrome
De la Iglesia, R., Loria-Kohen, V., Zulet, M., Martinez, J., Reglero, G., & Ramirez de Molina, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111877 · Cited by 168
“TG levels, as well as improvements in hypertension via depletion of SBP and DBP levels have been observed [35,37].”
BackgroundEvolution of pharmacological obesity treatments: focus on adverse side‐effect profiles
Krentz, A. J., Fujioka, K., & Hompesch, M. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12657 · Cited by 168
Intensive lifestyle intervention for obesity: principles, practices, and results.
Webb, V. L., & Wadden, T. A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.045 · Cited by 167
Self-citationEfficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
Lacroix, A., Gu, F., Gallardo, W., Pivonello, R., Yu, Y., Witek, P., Boscaro, M., Salvatori, R., Yamada, M., Tauchmanova, L., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30326-1 · Cited by 162
Optimal body weight for health and longevity: bridging basic, clinical, and population research
Fontana, L., & Hu, F. B. (2014) · Aging Cell · doi:10.1111/acel.12207 · Cited by 157
Green tea for weight loss and weight maintenance in overweight or obese adults
Jurgens, T. M., Whelan, A. M., Killian, L., Doucette, S., Kirk, S., & Foy, E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008650.pub2 · Cited by 156
Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
Wang, J. (2025) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2025.01.008 · Cited by 197
Shi, Q., Wang, Y., Hao, Q., Vandvik, P. O., Guyatt, G., Li, J., Chen, Z., Xu, S., Shen, Y., Ge, L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00351-9 · Cited by 155
Awosika, T., & Aluko, R. E. (2019) · International Journal of Food Science & Technology · doi:10.1111/ijfs.14087 · Cited by 163
Time-restricted eating: Watching the clock to treat obesity
Ezpeleta, M., Cienfuegos, S., Lin, S., Pavlou, V., Gabel, K., Tussing-Humphreys, L., & Varady, K. A. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.004 · Cited by 148
Weiss, T., Yang, L., Carr, R. D., Pal, S., Sawhney, B., Boggs, R., Rajpathak, S., & Iglay, K. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002517 · Cited by 152
Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes
TODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2388 · Cited by 152
Self-citationExercise and regulation of carbohydrate metabolism
Mul, J. D., Stanford, K. I., Hirshman, M. F., & Goodyear, L. J. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.020 · Cited by 151
Lip, G. Y. H., Lane, D. A., Lenarczyk, R., Boriani, G., Doehner, W., Benjamin, L. A., Fisher, M., Lowe, D., Sacco, R. L., Schnabel, R. B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac245 · Cited by 177
Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release
Garvey, W. T., Ryan, D. H., Bohannon, N. J. V., Kushner, R. F., Rueger, M., Dvorak, R. V., & Troupin, B. (2014) · Diabetes Care · doi:10.2337/dc14-0930 · Cited by 149
Hartmann‐Boyce, J., Johns, D. J., Jebb, S. A., Summerbell, C., Aveyard, P., & Behavioural Weight Management Review Group (2014) · Obesity Reviews · doi:10.1111/obr.12220 · Cited by 147
Schroder, J. D., Falqueto, H., Mânica, A., Zanini, D., de Oliveira, T., de Sá, C. A., Cardoso, A. M., & Manfredi, L. H. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02687-0 · Cited by 148
Bile acids and bariatric surgery
Albaugh, V. L., Banan, B., Ajouz, H., Abumrad, N. N., & Flynn, C. R. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.001 · Cited by 148
“Even this small degree of weight loss has been shown to be associated with decreased cardiovascular risk, but over time these improvements are lost with weight regain (Wing et al., 2011).”
BackgroundRecent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146
“The majority of circulating GIP refers to GIP(1-42), which gets cleaved from proGIP in the intestine by the action of PC1/3, but also a shorter form, GIP(130NH2), is produced in the intestine and the pancreatic a-cells by cleavage of proGIP by PC2 (149).”
BackgroundPenney, T. L., & Kirk, S. F. L. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302552 · Cited by 145
Effects on cardiovascular risk factors of weight losses limited to 5–10 %
Brown, J. D., Buscemi, J., Milsom, V., Malcolm, R., & O’Neil, P. M. (2016) · Translational Behavioral Medicine · doi:10.1007/s13142-015-0353-9 · Cited by 145
Hutchison, A. T., Liu, B., Wood, R. E., Vincent, A. D., Thompson, C. H., O’Callaghan, N. J., Wittert, G. A., & Heilbronn, L. K. (2019) · Obesity · doi:10.1002/oby.22345 · Cited by 145
Treatment of overweight and obesity in children and youth: a systematic review and meta-analysis
Peirson, L., Fitzpatrick-Lewis, D., Morrison, K., Warren, R., Usman Ali, M., & Raina, P. (2015) · CMAJ Open · doi:10.9778/cmajo.20140047 · Cited by 145
Obesity: A Stubbornly Obvious Target for Stroke Prevention
Kernan, W. N., Inzucchi, S. E., Sawan, C., Macko, R. F., & Furie, K. L. (2013) · Stroke · doi:10.1161/strokeaha.111.639922 · Cited by 144
Lifestyle medicine: the future of chronic disease management
Kushner, R. F., & Sorensen, K. W. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/01.med.0000433056.76699.5d · Cited by 172
Nadolsky, K., Garvey, W. T., Agarwal, M., Bonnecaze, A., Burguera, B., Chaplin, M. D., Griebeler, M. L., Harris, S. R., Schellinger, J. N., Simonetti, J., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.017 · Cited by 141
Cefalu, W. T., Stenlöf, K., Leiter, L. A., Wilding, J. P. H., Blonde, L., Polidori, D., Xie, J., Sullivan, D., Usiskin, K., Canovatchel, W., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3547-2 · Cited by 139
Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors
Teixeira, T. F. S., Grześkowiak, Ł., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. L. F., & Peluzio, M. C. G. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512002723 · Cited by 137
Weight loss is a critical factor to reduce inflammation
Bianchi, V. E. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.08.007 · Cited by 134
Ojo, O., Feng, Q.-Q., Ojo, O. O., & Wang, X.-H. (2020) · Nutrients · doi:10.3390/nu12113239 · Cited by 134
Nutritional considerations with antiobesity medications
Almandoz, J. P., Wadden, T. A., Tewksbury, C., Apovian, C. M., Fitch, A., Ard, J. D., Li, Z., Richards, J., Butsch, W. S., Jouravskaya, I., et al. (2024) · Obesity · doi:10.1002/oby.24067 · Cited by 134
“Complications are improved with weight reduction, and proportionally greater benefit is observed with greater weight reductions (Figure 1) [5 – 8].”
BackgroundSelf-citationTherapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin
Furmli, S., Elmasry, R., Ramos, M., & Fung, J. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-221854 · Cited by 134
Johnson, B. L., Blackhurst, D. W., Latham, B. B., Cull, D. L., Bour, E. S., Oliver, T. L., Williams, B., Taylor, S. M., & Scott, J. D. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.12.019 · Cited by 132
Obesity and cardiovascular risk
Kotsis, V., Jordan, J., Micić, D., Finer, N., Leitner, D. R., Toplak, H., Tokgözoğlu, L. S., Athyros, V. G., Elisaf, M., Filippatos, T. D., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001730 · Cited by 162
Weight Change and Survival after Breast Cancer in the After Breast Cancer Pooling Project
Caan, B. J., Kwan, M. L., Shu, X. O., Pierce, J. P., Patterson, R. E., Nechuta, S. J., Poole, E. M., Kroenke, C. H., Weltzien, E. K., Flatt, S. W., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0306 · Cited by 130
Patel, M. L., Hopkins, C. M., Brooks, T. L., & Bennett, G. G. (2019) · JMIR mHealth and uHealth · doi:10.2196/12209 · Cited by 129
Wadden, T. A., Chao, A. M., Moore, M., Tronieri, J. S., Gilden, A., Amaro, A., Leonard, S., & Jakicic, J. M. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00534-z · Cited by 129
“Similarly, the benefits of more moderate weight loss, achieved at a low cost with traditional lifestyle modification, should not be overlooked in preventing type 2 diabetes [20] or in reducing mild elevations in blood pressure and other cardiometabolic risk factors [24].”
BackgroundSelf-citationINTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
Dedov, I. I., Shestakova, M. V., Mel'nichenko, G. A., Mazurina, N. V., Andreeva, E. N., Bondarenko, I. Z., Руслановна, Г. З., Dzgoeva, F. K., Елисеев, М. С., Ershova, E. V., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12714 · Cited by 206
Fortin, S. M., Lipsky, R. K., Lhamo, R., Chen, J., Kim, E., Borner, T., Schmidt, H. D., & Hayes, M. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8071 · Cited by 127
Unick, J. L., Hogan, P. E., Neiberg, R. H., Cheskin, L. J., Dutton, G. R., Evans‐Hudnall, G., Jeffery, R., Kitabchi, A. E., Nelson, J. A., Pi‐Sunyer, F. X., et al. (2014) · Obesity · doi:10.1002/oby.20777 · Cited by 127
“These 1-year thresholds were chosen because they are often used to define clinically significant weight loss and have been shown to be associated with significant improvements in long-term health outcomes (18-20).”
MethodSelf-citationBajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s005 · Cited by 277
Self-citationWeight loss and serum lipids in overweight and obese adults: A systematic review and meta-analysis
Hasan, B., Nayfeh, T., Alzuabi, M., Wang, Z., Kuchkuntla, A. R., Prokop, L. J., Newman, C. B., Murad, M. H., & Rajjo, T. I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa673 · Cited by 126
Phelan, S., Hagobian, T., Brannen, A., Hatley, K. E., Schaffner, A., Muñoz-Christian, K., & Tate, D. F. (2017) · JAMA · doi:10.1001/jama.2017.7119 · Cited by 126
The Action for Health in Diabetes (Look AHEAD) Study Group (2016) · Diabetes Care · doi:10.2337/dc16-0509 · Cited by 125
“In our previously reported 1-year results (8), we noted that weight loss did not affect LDL-C or DBP levels; the current year 4 data continue to show no systematic effects of weight loss on these outcomes.”
BackgroundResultBennett, G. G., Foley, P., Levine, E., Whiteley, J., Askew, S., Steinberg, D. M., Batch, B., Greaney, M. L., Miranda, H., Wroth, T. H., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9263 · Cited by 125
Obesity and cardiovascular disease: an ESC clinical consensus statement
Koskinas, K. C., Craenenbroeck, E. M. V., Antoniades, C. A., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae279 · Cited by 148
Thomas, C. E., Mauer, E. A., Shukla, A. P., Rathi, S., & Aronne, L. J. (2016) · Obesity · doi:10.1002/oby.21533 · Cited by 124
Amin, F., Islam, N., Anila, N., & Gilani, A. H. (2015) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2015.01.008 · Cited by 139
Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
Raveendran, A. V. (2018) · European Endocrinology · doi:10.17925/ee.2018.14.2.31 · Cited by 122
Grams, J. M., & Garvey, W. T. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0155-x · Cited by 146
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective
De Block, C., Bailey, C., Wysham, C., Hemmingway, A., Allen, S. E., & Peleshok, J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14831 · Cited by 121
Jordan, J., Astrup, A., Engeli, S., Narkiewicz, K., Day, W. W., & Finer, N. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000145 · Cited by 121
Kroes, M., Osei-Assibey, G., Baker-Searle, R., & Huang, J. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1128403 · Cited by 119
Management of diabetic dyslipidemia: An update
Jialal, I., & Singh, G. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i5.280 · Cited by 120
An assessment by the Statin Diabetes Safety Task Force: 2014 update
Maki, K. C., Ridker, P. M., Brown, W. V., Grundy, S. M., & Sattar, N. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.02.012 · Cited by 119
Yamaguchi, Y., Adachi, K., Sugiyama, T., Shimozato, A., Ebi, M., Ogasawara, N., Funaki, Y., Goto, C., Sasaki, M., & Kasugai, K. (2016) · Digestion · doi:10.1159/000447690 · Cited by 118
Cardel, M. I., Newsome, F. A., Pearl, R. L., Ross, K. M., Dillard, J. R., Miller, D. R., Hayes, J. F., Wilfley, D., Keel, P. K., Dhurandhar, E. J., et al. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.01.004 · Cited by 116
Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery
Cummings, D. E., & Cohen, R. V. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70198-0 · Cited by 116
Safety and tolerability of new-generation anti-obesity medications: a narrative review
Patel, D. K., & Stanford, F. C. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1435129 · Cited by 116
Demystifying the management of hypertriglyceridaemia
Watts, G. F., Ooi, E. M. M., & Chan, D. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.140 · Cited by 115
GLP-1 based therapeutics: simultaneously combating T2DM and obesity
Heppner, K. M., & Perez-Tilve, D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00092 · Cited by 115
Weight Loss and Hypertension in Obese Subjects
Fantin, F., Giani, A., Zoico, E., Rossi, A. P., Mazzali, G., & Zamboni, M. M. (2019) · Nutrients · doi:10.3390/nu11071667 · Cited by 144
Madigan, C. D., Graham, H. E., Sturgiss, E., Kettle, V. E., Gokal, K., Biddle, G., Taylor, G. M. J., & Daley, A. J. (2022) · BMJ · doi:10.1136/bmj-2021-069719 · Cited by 114
Singh, B., Ahmed, M., Staiano, A. E., Gough, C., Petersen, J., Vandelanotte, C., Kracht, C., Huong, C., Yin, Z., Vasiloglou, M. F., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01172-y · Cited by 115
Horn, D. B., Almandoz, J. P., & Look, M. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2051366 · Cited by 114
“Greater improvements were also seen in patients who had greater weight loss [45].”
BackgroundInfluentialThe Treatment of Type 2 Diabetes
Pfeiffer, A. F. H., & Klein, H. H. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0069 · Cited by 209
Mindfulness Approaches and Weight Loss, Weight Maintenance, and Weight Regain
Dunn, C., Haubenreiser, M., Johnson, M., Nordby, K., Aggarwal, S., Myer, S., & Thomas, C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0299-6 · Cited by 147
Improving obesity and blood pressure
Tanaka, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0348-x · Cited by 122
Effect of Age and Weight on Physical Activity
Suryadinata, R. V., Wirjatmadi, B., Adriani, M., & Lorensia, A. (2020) · Journal of Public Health Research · doi:10.4081/jphr.2020.1840 · Cited by 174
New horizons. A new paradigm for treating to target with second-generation obesity medications
Garvey, W. T. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab848 · Cited by 110
Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed
Vijayvergia, N., & Denlinger, C. S. (2015) · Journal of Personalized Medicine · doi:10.3390/jpm5030243 · Cited by 128
Weight regaining: From statistics and behaviors to physiology and metabolism
Anastasiou, C. A., Karfopoulou, E., & Yannakoulia, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.006 · Cited by 119
Cardiometabolic risk factors in vegans; A meta-analysis of observational studies
Benatar, J. R., & Stewart, R. A. H. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209086 · Cited by 109
Machado, A. M., Guimarães, N. S., Bocardi, V. B., da Silva, T. P. R., Carmo, A. S. D., Menezes, M. C. D., & Duarte, C. K. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.03.020 · Cited by 109
Thomas, J. G., Bond, D. S., Raynor, H. A., Papandonatos, G. D., & Wing, R. R. (2019) · Obesity · doi:10.1002/oby.22410 · Cited by 108
“To gain access, a data-sharing agreement is required that provides for (1) a commitment to use the data for research purposes only, (2) a commitment to securing the data using appropriate computer technology, (3) a commitment to destroying or returning the data after analyses are completed, and (4) a commitment not to…”
BackgroundSelf-citationInacio, M. C. S., Kritz‐Silverstein, D. C., Raman, R., Macera, C. A., Nichols, J. F., Shaffer, R. A., & Fithian, D. C. (2013) · The Journal of Arthroplasty · doi:10.1016/j.arth.2013.07.030 · Cited by 115
Taylor, P. J., Thompson, C. H., & Brinkworth, G. D. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12807 · Cited by 105
Chinese Guideline on the Primary Prevention of Cardiovascular Diseases
Chinese Society of Cardiology of Chinese Medical Association, C. D. P. A. R. C. O. C. A. O. R. M. (2021) · Cardiology Discovery · doi:10.1097/cd9.0000000000000025 · Cited by 133
Metadata
- Authors
- Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., & the Look AHEAD Research Group
- Affiliations
- Brown University (US)
- Wake Forest University Health Sciences (US)
- University of Pennsylvania (US)
- University of Alabama at Birmingham (US)
- National Institutes of Health (US)
- University of Colorado Health (US)
- Johns Hopkins University (US)
- Roybal Comprehensive Health Center, Los Angeles, California
- Corresponding author
- Wing, Rena R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-06-17
- Volume
- 34
- Issue
- 7
- Pages
- 1481-1486
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3120182
- OpenAlex
- W2096048424
- Semantic Scholar
- e255352983f0832ba4b41a003633e20e137c2853
- Cited by
- 1,828
- References
- 31
- Citations by year
- 2026: 86 · 2025: 153 · 2024: 136 · 2023: 145 · 2022: 146 · 2021: 143 · 2020: 139 · 2019: 146 · 2018: 126 · 2017: 125 · 2016: 137 · 2015: 99 · 2014: 104 · 2013: 80 · 2012: 49
- FWCI
- 64.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079637, P30DK017047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- weight loss, type 2 diabetes, cardiovascular risk factors, obesity, overweight, Look AHEAD trial, glycemic control, HbA1c, blood pressure, triglycerides, HDL cholesterol, LDL cholesterol
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Life Style, Male, Middle Aged, Obesity, Patient Education as Topic, Risk Factors, Weight Loss, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.